Detailed Information on Publication Record
2012
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
SORBI, S., J. HORT, T. ERKINJUNTTI, T. FLADBY, G. GAINOTTI et. al.Basic information
Original name
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
Authors
SORBI, S. (380 Italy), J. HORT (203 Czech Republic), T. ERKINJUNTTI (246 Finland), T. FLADBY (578 Norway), G. GAINOTTI (380 Italy), H. GURVIT (792 Turkey), B. NACMIAS (380 Italy), F. PASQUIER (250 France), B. O. POPESCU (642 Romania), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), D. RELIGA (616 Poland), R. RUSINA (203 Czech Republic), M. ROSSOR (826 United Kingdom of Great Britain and Northern Ireland), R. SCHMIDT (40 Austria), E. STEFANOVA (688 Serbia), J. D. WARREN (826 United Kingdom of Great Britain and Northern Ireland) and P. SCHELTENS (528 Netherlands)
Edition
European Journal of Neurology, Hoboken, USA, WILEY-BLACKWELL, 2012, 1351-5101
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.162
RIV identification code
RIV/00216224:14740/12:00064609
Organization unit
Central European Institute of Technology
UT WoS
000307729700014
Keywords in English
dementia; diagnosis; guideline; management; recommendation; review; treatment
Tags
International impact, Reviewed
Změněno: 15/4/2013 10:46, Olga Křížová
Abstract
V originále
Background and objectives The last version of the EFNS dementia guidelines is from 2007. In 2010, the revised guidelines for Alzheimer's disease (AD) were published. The current guidelines involve the revision of the dementia syndromes outside of AD, notably vascular cognitive impairment, frontotemporal lobar degeneration, dementia with Lewy bodies, corticobasal syndrome, progressive supranuclear palsy, Parkinson's disease dementia, Huntington's disease, prion diseases, normal-pressure hydrocephalus, limbic encephalitis and other toxic and metabolic disorders. The aim is to present a peer-reviewed evidence-based statement for the guidance of practice for clinical neurologists, geriatricians, psychiatrists and other specialist physicians responsible for the care of patients with dementing disorders. It represents a statement of minimum desirable standards for practice guidance. Methods The task force working group reviewed evidence from original research articles, meta-analyses and systematic reviews, published by June 2011. The evidence was classified (I, II, III, IV) and consensus recommendations graded (A, B, or C) according to the EFNS guidance. Where there was a lack of evidence, but clear consensus, good practice points were provided. Results and conclusions New recommendations and good practice points are made for clinical diagnosis, blood tests, neuropsychology, neuroimaging, electroencephalography, cerebrospinal fluid (CSF) analysis, genetic testing, disclosure of diagnosis, treatment of behavioural and psychological symptoms in dementia, legal issues, counselling and support for caregivers. All recommendations were revised as compared with the previous EFNS guidelines. The specialist neurologist together with primary care physicians play an important role in the assessment, interpretation and treatment of symptoms, disability and needs of dementia patients.
Links
| ED1.1.00/02.0068, research and development project |
|